In prostate cancer, an activated nuclear AR binds to and reduces the DNA binding capacity of FOXO1 in an Akt-independent manner, affecting the expression of the proapoptotic genes, such as Fas [223]. The gene discussed is FOXO1; the disease is Familial prostate cancer.